About Syqe
Who Are We?
Syqe Medical, an innovative MedTech company that developed a breakthrough technology for the administration of medical cannabis by inhalation. We set out on our journey in 2011 with a vision that excited us greatly: to reduce the pain and suffering of as many patients as possible, in the fastest possible way, through advanced technologies and insistent thinking of what our patients really need.
We recognize the beneficial therapeutic effect of medical cannabis and are determined to lead a global change in the standardization of cannabis treatment. We want to transform it into an personalized treatment with a rapid effect and minimum adverse effects. At the same time, we want to give physicians the ability to treat patients using cannabis in compliance with the principles of the standard of care of metered dosing, lowest effective dose, and safety of use, as well as careful clinical supervision. All of this is made possible with a medical device that is supported by clinical trials and does not expose the patients to smoking damage.
What Do We Do?
We developed the SyqeAir Inhaler – a unique technology that allows physicians and patients to manage cannabis treatment in compliance with the principles of the standard of care of metered dosing, lowest effective dose, and safety of use. A groundbreaking Inhaler whose efficacy, safety, and ability to achieve an optimal balance between reduction of pain intensity and control of the psychoactive effects have been demonstrated in clinical trials.
With each inhalation, a consistent and metered amount of THC is released from a raw medical cannabis inflorescence with a full, uniform, and consistent spectrum of the active ingredients. The cannabis is sealed in a designated cartridge, which is loaded securely into the Inhaler, ready for use. The cartridge contains 60 VaporChips (each the size of a sim card), and each VaporChip contains a uniform amount of raw cannabis inflorescence grown in compliance with GMP’s strict production requirements.
Our Story
The call to set out on our journey stemmed from human suffering and the painful realization that medical cannabis, which has such a beneficial effect on pain, is unable to meet all needs. It is not metered-dose or uniform, it is unpredictable, and it does not comply with any standard of care.
We felt immense frustration. We knew that cannabis was the solution the world was waiting for. However, in practice, it gained a negative reputation, misconceptions, and unanswered questions since it is classified as a dangerous drug, and there were no clinical studies to address or counter them.
Today, we have a groundbreaking technology that allows physicians and patients to manage cannabis treatment in compliance with the principles of the standard of care of metered dosing, lowest effective dose, and safety of use. A user-friendly platform based on clinical trials that enables a reduction in pain intensity starting within 5 minutes as well as improving sleep quality, with minimum or no psychoactive adverse effects.
Medical cannabis may not prevent a person from dying, but medical cannabis treatment using the SyqeAir Inhaler undoubtedly saves the quality of life of aching people and allows them to breathe again.
Our Team
Content
